UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.153

Sortiert nach

Comparative benefit-cost analysis of the abecedarian program and its policy implications

Economics of education review, 2007-02, Vol.26 (1), p.113-125

2007

Volltextzugriff (PDF)

Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit

Vaccine, 1997-06, Vol.15 (8), p.869-873

1997

Volltextzugriff (PDF)

Long-Term Cognitive and Academic Effects of Early Childhood Education on Children in Poverty

Preventive medicine, 1998-03, Vol.27 (2), p.204-207

Steven Barnett, W.

1998

Volltextzugriff (PDF)

Priming B cell-mediated anti-HIV envelope responses by vaccination allows for the long-term control of infection in macaques exposed to a R5-tropic SHIV

Virology (New York, N.Y.), 2004-03, Vol.320 (1), p.167-180

2004

Volltextzugriff (PDF)

Functionally-inactive and immunogenic Tat, Rev and Nef DNA vaccines derived from sub-Saharan subtype C human immunodeficiency virus type 1 consensus sequences

Vaccine, 2005-01, Vol.23 (9), p.1158-1169

2005

Volltextzugriff (PDF)

Characterization of human immunodeficiency virus type 1 strains recovered from the bowel of infected individuals

Virology (New York, N.Y.), 1991-06, Vol.182 (2), p.802-809

1991

Volltextzugriff (PDF)

Biologic heterogeneity of human immunodeficiency virus type 2 (HIV-2) strains

Virology (New York, N.Y.), 1990-10, Vol.178 (2), p.527-534

1990

Volltextzugriff (PDF)

Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination

Virology (New York, N.Y.), 2008-06, Vol.375 (2), p.315-320

2008

Volltextzugriff (PDF)

DNA-immunization with a V2 deleted HIV-1 envelope elicits protective antibodies in macaques

Immunology letters, 2001-11, Vol.79 (1), p.47-55

2001

Volltextzugriff (PDF)

Species Tropism of Chimeric SHIV Clones Containing HIV-1 Subtype-A and Subtype-E Envelope Genes

Virology (New York, N.Y.), 2002-07, Vol.298 (2), p.189-199

2002

Volltextzugriff (PDF)

Neutralizing antibody responses to subtype B and C adjuvanted HIV envelope protein vaccination in rabbits

Virology (New York, N.Y.), 2009-04, Vol.387 (1), p.147-156

2009

Volltextzugriff (PDF)

Test of models for replication of simian virus 40 DNA following ultraviolet irradiation

Biophysical journal, 1984-09, Vol.46 (3), p.307-321

1984

Volltextzugriff (PDF)

Isolation and characterization of monoclonal antibodies elicited by trimeric HIV-1 Env gp140 protein immunogens

Virology (New York, N.Y.), 2007-09, Vol.366 (2), p.433-445

2007

Volltextzugriff (PDF)

Immunization with HIV-1 SF162-derived Envelope gp140 proteins does not protect macaques from heterologous simian-human immunodeficiency virus SHIV89.6P infection

Virology (New York, N.Y.), 2006-06, Vol.349 (2), p.276-289

2006

Volltextzugriff (PDF)

A simple one-step method for the preparation of HIV-1 envelope glycoprotein immunogens based on a CD4 mimic peptide

Virology (New York, N.Y.), 2008-11, Vol.381 (2), p.241-250

2008

Volltextzugriff (PDF)

Structural characteristics correlate with immune responses induced by HIV envelope glycoprotein vaccines

Virology (New York, N.Y.), 2006-08, Vol.352 (1), p.131-144

2006

Volltextzugriff (PDF)

Cloning SV40 HindIII restriction fragments into M13 bacteriophage

Gene, 1982-04, Vol.18 (1), p.97-100

1982

Volltextzugriff (PDF)

Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies

Virology (New York, N.Y.), 2006-11, Vol.355 (2), p.138-151

2006

Volltextzugriff (PDF)

Noncoordinate expression of Drosophila glue genes: Sgs-4 is expressed at many stages and in two different tissues

Developmental biology, 1990-08, Vol.140 (2), p.362-373

1990

Volltextzugriff (PDF)

Development of V2-deleted trimeric envelope vaccine candidates from human immunodeficiency virus type 1 (HIV-1) subtypes B and C

Microbes and infection, 2005-11, Vol.7 (14), p.1386-1391

2005

Volltextzugriff (PDF)

Candidate HIV-1 gp140DeltaV2, Gag and Tat vaccines protect against experimental HIV-1/MuLV challenge

Vaccine, 2007-09, Vol.25 (39-40), p.6882-6890

2007

Volltextzugriff (PDF)

Evaluation of human immunodeficiency virus type 1 subtype C gag, pol, and gagpol DNA and alphavirus replicon vaccines

Vaccine, 2006-04, Vol.24 (15), p.2755-2763

2006

Volltextzugriff (PDF)

And so we plough along: the nature and nurture of partnerships for inquiry

Early childhood research quarterly, 2001-01, Vol.16 (1), p.3-17

2001

Volltextzugriff (PDF)

Molecular cloning of the human immunodeficiency virus subtype 2 strain HIV-2 sub(UC2)

Virology (New York, N.Y.), 1996-08, Vol.222 (1), p.257-261

1996

Volltextzugriff (PDF)

From the Guest Editors

Early childhood research quarterly, 2001-01, Vol.16 (1), p.1-2

2001

Volltextzugriff (PDF)

1 – 25 von 1.153

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.128)
Mit Volltextzugriff
(1.105)

Sprache

Englisch
(1.152)
Japanisch
(100)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(671)
Life Sciences & Biomedicine
(446)
Humans
(318)
Biological And Medical Sciences
(225)
Female
(221)
Physical Sciences
(217)
Male
(193)
Chemistry
(150)
Animals
(149)
Medical Sciences
(139)
Exact Sciences And Technology
(117)
Social Sciences
(116)
Adult
(109)
Physics
(109)
Fundamental And Applied Biological Sciences. Psychology
(99)
Technology
(94)
Middle Aged
(87)
Chemistry, Analytical
(72)
Psychology
(72)
Analytical Chemistry
(66)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Comparative benefit-cost analysis of the abecedarian program and its policy implications

Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit

Long-Term Cognitive and Academic Effects of Early Childhood Education on Children in Poverty

Priming B cell-mediated anti-HIV envelope responses by vaccination allows for the long-term control of infection in macaques exposed to a R5-tropic SHIV

Functionally-inactive and immunogenic Tat, Rev and Nef DNA vaccines derived from sub-Saharan subtype C human immunodeficiency virus type 1 consensus sequences

Characterization of human immunodeficiency virus type 1 strains recovered from the bowel of infected individuals

Biologic heterogeneity of human immunodeficiency virus type 2 (HIV-2) strains

Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination

DNA-immunization with a V2 deleted HIV-1 envelope elicits protective antibodies in macaques

Species Tropism of Chimeric SHIV Clones Containing HIV-1 Subtype-A and Subtype-E Envelope Genes

Neutralizing antibody responses to subtype B and C adjuvanted HIV envelope protein vaccination in rabbits

Test of models for replication of simian virus 40 DNA following ultraviolet irradiation

Isolation and characterization of monoclonal antibodies elicited by trimeric HIV-1 Env gp140 protein immunogens

Immunization with HIV-1 SF162-derived Envelope gp140 proteins does not protect macaques from heterologous simian-human immunodeficiency virus SHIV89.6P infection

A simple one-step method for the preparation of HIV-1 envelope glycoprotein immunogens based on a CD4 mimic peptide

Structural characteristics correlate with immune responses induced by HIV envelope glycoprotein vaccines

Cloning SV40 HindIII restriction fragments into M13 bacteriophage

Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies

Noncoordinate expression of Drosophila glue genes: Sgs-4 is expressed at many stages and in two different tissues

Development of V2-deleted trimeric envelope vaccine candidates from human immunodeficiency virus type 1 (HIV-1) subtypes B and C

Candidate HIV-1 gp140DeltaV2, Gag and Tat vaccines protect against experimental HIV-1/MuLV challenge

Evaluation of human immunodeficiency virus type 1 subtype C gag, pol, and gagpol DNA and alphavirus replicon vaccines

And so we plough along: the nature and nurture of partnerships for inquiry

Molecular cloning of the human immunodeficiency virus subtype 2 strain HIV-2 sub(UC2)

From the Guest Editors

Aktive Filter

Suchergebnisse filtern